Kai Gan

417 total citations
22 papers, 293 citations indexed

About

Kai Gan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kai Gan has authored 22 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Kai Gan's work include Bone Metabolism and Diseases (3 papers), Signaling Pathways in Disease (3 papers) and NF-κB Signaling Pathways (3 papers). Kai Gan is often cited by papers focused on Bone Metabolism and Diseases (3 papers), Signaling Pathways in Disease (3 papers) and NF-κB Signaling Pathways (3 papers). Kai Gan collaborates with scholars based in China and Australia. Kai Gan's co-authors include Guiyuan Li, Bin Xu, Shourong Shen, Wei Tong, Minghua Wu, Yunlian Tang, Zhaoyang Zeng, Xiaoling Li, Qiong Chen and Ke Tang and has published in prestigious journals such as FEBS Letters, Chemosphere and Molecular Biology of the Cell.

In The Last Decade

Kai Gan

19 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Gan China 11 184 54 44 34 33 22 293
Lian Zuo China 8 143 0.8× 55 1.0× 71 1.6× 21 0.6× 45 1.4× 12 304
Saeideh Nakhaei‐Rad Germany 12 309 1.7× 28 0.5× 54 1.2× 29 0.9× 55 1.7× 23 413
James Moody United States 8 317 1.7× 23 0.4× 63 1.4× 39 1.1× 48 1.5× 15 417
Cindy Zer United States 8 306 1.7× 38 0.7× 65 1.5× 47 1.4× 11 0.3× 12 415
Kshitij Parag‐Sharma United States 12 226 1.2× 38 0.7× 39 0.9× 30 0.9× 20 0.6× 20 309
Justyna M. Meissner Poland 10 200 1.1× 95 1.8× 45 1.0× 58 1.7× 64 1.9× 19 370
Satoko Shimamura United Kingdom 4 264 1.4× 62 1.1× 84 1.9× 44 1.3× 50 1.5× 5 373
Li Gong China 8 161 0.9× 49 0.9× 64 1.5× 15 0.4× 30 0.9× 23 266
Azusa Inagaki Japan 8 334 1.8× 40 0.7× 41 0.9× 42 1.2× 27 0.8× 13 403
Mayuri Prasad United States 10 236 1.3× 69 1.3× 52 1.2× 42 1.2× 17 0.5× 15 351

Countries citing papers authored by Kai Gan

Since Specialization
Citations

This map shows the geographic impact of Kai Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Gan more than expected).

Fields of papers citing papers by Kai Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Gan. The network helps show where Kai Gan may publish in the future.

Co-authorship network of co-authors of Kai Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Gan. A scholar is included among the top collaborators of Kai Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Gan. Kai Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Xu, Yuting, Kai Gan, Huawei Wang, et al.. (2024). The association between hepatitis B virus and semen quality: a systematic review and meta-analysis. BMC Urology. 24(1). 47–47. 2 indexed citations
4.
Gan, Kai, Jian Huang, Junchun Chen, et al.. (2024). Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways. Cell Death Discovery. 10(1). 86–86. 10 indexed citations
5.
Huang, Jian, Dezhi Song, Kai Gan, et al.. (2024). Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS. Phytotherapy Research. 38(9). 4650–4666. 7 indexed citations
6.
Chen, Weiwei, Kai Gan, Chaofeng Wang, et al.. (2023). Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis. Journal of Translational Medicine. 21(1). 839–839. 6 indexed citations
7.
Tong, Wei & Kai Gan. (2023). Towards Realistic Long-Tailed Semi-Supervised Learning: Consistency is All You Need. 3469–3478. 17 indexed citations
8.
Li, Xiaohong, Shunling Li, Kai Gan, et al.. (2022). Bacterial-driven upcycling spent Ag into high-performance catalyst for toxic organics reduction. Chemosphere. 305. 135421–135421. 7 indexed citations
9.
Gan, Kai, Keying Zhang, Li Yu, et al.. (2022). Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma. Frontiers in Genetics. 13. 1021163–1021163. 1 indexed citations
10.
Gan, Kai, et al.. (2021). The Clinical Significance and Prognostic Value of HER2 Expression in Bladder Cancer: A Meta-Analysis and a Bioinformatic Analysis. Frontiers in Oncology. 11. 653491–653491. 24 indexed citations
11.
Gao, Yue, et al.. (2021). SP1 Expression and the Clinicopathological Features of Tumors: A Meta-Analysis and Bioinformatics Analysis. Pathology & Oncology Research. 27. 581998–581998. 21 indexed citations
12.
Gao, Yue, et al.. (2021). Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and Meta-Analysis. Cancer Control. 28. 1149432719–1149432719. 13 indexed citations
13.
Gan, Kai, Zhitao Li, Yuan Fang, et al.. (2021). Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis. Transplant Immunology. 69. 101476–101476. 11 indexed citations
14.
Wu, Minghua, Chen Huang, Xiayu Li, et al.. (2007). LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses. Journal of Cellular Physiology. 214(1). 65–74. 28 indexed citations
16.
Wu, Minghua, Kai Gan, Chen Huang, et al.. (2006). LRRC4 controls in vitro invasion of glioblastoma cells through inhibiting RPTP-zeta expression. Journal of Neuro-Oncology. 80(2). 133–142. 17 indexed citations
17.
Zhang, Qiuhong, Minghua Wu, Lili Wang, et al.. (2005). Profiling of Differentially Expressed Genes in <italic>LRRC4</italic> Overexpressed Glioblastoma Cells by cDNA Array. Acta Biochimica et Biophysica Sinica. 37(10). 680–687. 5 indexed citations
18.
Li, Zheng, Shiguo Zhu, Kai Gan, et al.. (2005). Poly-L-lysine-Modified Silica Nanoparticles: A Potential Oral Gene Delivery System. Journal of Nanoscience and Nanotechnology. 5(8). 1199–1203. 41 indexed citations
19.
Zhang, Qiuhong, Jieru Wang, Songqing Fan, et al.. (2005). Expression and functional characterization of LRRC4, a novel brain‐specific member of the LRR superfamily. FEBS Letters. 579(17). 3674–3682. 31 indexed citations
20.
Xiang, Juanjuan, Xinmin Nie, Jingqun Tang, et al.. (2004). [In vitro gene transfection by magnetic iron oxide nanoparticles and magnetic field increases transfection efficiency].. PubMed. 26(2). 71–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026